Nimesulide Eg

Nimesulide, the active ingredient in Nimesulide Eg, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for systemic use. It is employed to relieve acute pain, reduce fever, and manage inflammatory conditions such as dysmenorrhea, osteoarthritis and low‑back pain in adult patients.

GNH USA supplies Nimesulide Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nimesulide acts as an NSAID that reduces inflammation and pain through COX‑2 inhibition. - Acute pain: provides rapid analgesic relief for short‑term painful episodes. - Dysmenorrhea: lessens menstrual cramps and associated discomfort. - Osteoarthritis: helps control joint pain and stiffness in chronic degenerative disease. - Low back pain: alleviates muscular and spinal discomfort. - Fever: lowers elevated body temperature in febrile states.

Nimesulide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or pruritus. - Elevated liver enzymes detected on routine labs.

Serious or Rare Side Effects: - Hepatotoxicity: potentially severe liver injury. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Blood dyscrasias such as agranulocytosis. - Acute renal impairment. - Severe hypersensitivity reactions including anaphylaxis.

Before prescribing Nimesulide, clinicians should consider several safety measures. - Assess liver function: obtain baseline hepatic enzymes and monitor periodically. - Avoid in patients with known hypersensitivity to NSAIDs or sulfonamides. - Use the lowest effective dose for the shortest duration required. - Monitor renal function in individuals with pre‑existing kidney disease or dehydration. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nimesulide can affect the activity of several other medicines.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Lithium: elevated serum lithium levels.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (e.g., ACE inhibitors, diuretics): possible reduction in blood pressure control. - Methotrexate: decreased clearance leading to toxicity.